KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) EBITDA (2016 - 2025)

Omega Healthcare Investors' EBITDA history spans 13 years, with the latest figure at $223.0 million for Q4 2025.

  • For Q4 2025, EBITDA rose 28.27% year-over-year to $223.0 million; the TTM value through Dec 2025 reached $839.5 million, up 30.66%, while the annual FY2025 figure was $839.5 million, 30.66% up from the prior year.
  • EBITDA for Q4 2025 was $223.0 million at Omega Healthcare Investors, down from $249.5 million in the prior quarter.
  • Across five years, EBITDA topped out at $252.9 million in Q1 2022 and bottomed at $93.3 million in Q1 2023.
  • The 4-year median for EBITDA is $166.5 million (2024), against an average of $169.0 million.
  • The largest annual shift saw EBITDA plummeted 63.12% in 2023 before it soared 50.24% in 2025.
  • A 4-year view of EBITDA shows it stood at $106.5 million in 2022, then increased by 13.87% to $121.3 million in 2023, then surged by 43.41% to $173.9 million in 2024, then rose by 28.27% to $223.0 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's EBITDA are $223.0 million (Q4 2025), $249.5 million (Q3 2025), and $200.1 million (Q2 2025).